Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06359106

Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
1,176 (estimated)
Sponsor
China Medical University, China · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery.

Detailed description

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery. the investigators planned to enroll 1098 subjects aged \> 65 years for laparoscopic gastrointestinal surgery at 19 clinical trial centers in China, randomized in a 1:1 ratio, to use two inhaled oxygen concentrations during surgery. All patients will be performed via the lung-protective ventilation strategy. The respiratory parameters are VT: 6-8ml/kg, PEEP: 6-8 cmh2O, RR: 1:2, and respiratory rate will be adjusted by maintaining a partial pressure of carbon dioxide at 35-45 mmHg. Manual lung recruitment maneuvers will be performed after tracheal intubation and before tracheal extubation. The main outcome measure was the oxygenation index on the postoperative 48h. The secondary outcome measures were the 7-day postoperative pulmonary complications and 30-day mortality rates et al.

Conditions

Interventions

TypeNameDescription
DRUG80% OxygenAfter successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 80%, and the total gas flow rate will be set at 2L/minute.
DRUG40% OxygenAfter successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 40%, and the total gas flow rate will be set at 2L/minute.

Timeline

Start date
2024-07-02
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2024-04-11
Last updated
2026-01-26

Locations

16 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06359106. Inclusion in this directory is not an endorsement.